After successfully completing STTR Phase I funded design of a Marburg virus prophylactic countermeasure vaccine, Flow Pharma has received a follow-on Phase II STTR contract award to transition into ...
Flow Pharma is now a full-stack biotech company in the neoantigen space OSLO, Norway--(BUSINESS WIRE)--Flow Pharma Inc., a San Francisco Bay Area biotechnology company focused on developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results